CaryHealth

Overview

CaryHealth is a digital-pharmacy and direct-to-patient platform that combines 50-state specialty-pharmacy fulfillment with proprietary AI tools (Clair clinical co-pilot, OneDash care-gap automation, CaryConnect DTP) for pharma manufacturers, health plans, providers, and patients. Founded in 2017 and headquartered in Washington, D.C., CaryHealth ranked No. 96 on the 2025 Inc. 5000 with 3,752% three-year revenue growth.

CaryHealth is best read as a digital-pharmacy and DTP platform rather than as a classic high-touch hub-services vendor for rare disease, REMS-heavy oncology, or fully outsourced field-reimbursement programs. Buyers should treat fulfillment, adherence, and DTP enrollment as the core, and BV / PA / copay infrastructure as scope items to confirm against incumbent hub partners.

Hub Capability Model

The framework below standardizes how Rx Almanac evaluates hub-services capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, CaryHealth is evaluated as a digital-pharmacy and direct-to-patient platform with hub-adjacent intake and fulfillment.

Capability	Buyer should compare	CaryHealth readout
Therapy initiation and enrollment intake	Digital and human intake, eConsent, missing-information resolution, provider/patient portals, and clean case creation.	Core intake workflow. CaryConnect is the branded direct-to-patient enrollment, engagement, and fulfillment platform for pharma manufacturers; April 2026 Cipher Pharmaceuticals Natroba launch is a named program signal.
Benefits verification and coverage triage	Medical/pharmacy benefit verification, eligibility checks, payer-policy lookup, coverage routing, and speed from referral to actionable case.	Adjacent / diligence area. BV is integrated into the pharmacy workflow, not positioned as a standalone hub product; confirm depth, payer connections, and turnaround vs. dedicated hub vendors.
Prior authorization, appeals, and reimbursement casework	PA initiation, payer-specific forms, clinical documentation, appeals, denial management, and field reimbursement handoffs.	Diligence area. PA workflow runs through the pharmacy and DTP stack; ask for therapy-specific PA depth, appeals handling, and field reimbursement handoff in RFP.
Affordability, PAP, and copay operations	Copay, free-drug, bridge, foundation, income verification, PAP renewal, and gross-to-net sensitive affordability logic.	Diligence area. Copay and affordability tools are part of the DTP experience; ask for PAP, foundation-grant, and bridge-program operations explicitly.
Patient engagement and adherence operations	Omnichannel reminders, clinical education, nursing or training escalation, persistence outreach, and patient-facing support quality.	Core engagement model. AI-driven adherence and engagement built into the digital pharmacy workflow; reported +15% adherence improvement and 73% care-gap closure rates.
Fulfillment, specialty pharmacy, and distribution coordination	Routing to SPs, non-commercial dispensing, DTP shipment, sample/replacement product, 3PL, and cold-chain handoffs.	Core fulfillment handoff. CaryRx specialty pharmacy is licensed in all 50 states with same-day delivery; full-service fulfillment is the core operating layer.
Program reporting, integrations, and governance	Manufacturer dashboards, KPI reporting, CRM/EHR/API integrations, SLA governance, and operating visibility across vendors.	Diligence area. Telehealth and fulfillment integrations exist; ask for live manufacturer dashboards, KPI definitions, and CRM/data-lake integration pathways.

Buyer Fit

• Program fit: Evaluate CaryHealth when a launch needs a 50-state digital specialty pharmacy plus DTP enrollment, AI-driven adherence, and same-day delivery as the core operating model.
• Best-fit buyers: Pharma manufacturers and biotech launch teams in self-administered specialty and small-molecule programs; health plans pursuing HEDIS care-gap closure via OneDash; providers and health systems integrating telehealth with pharmacy fulfillment.
• Less ideal fit: Rare disease, REMS-heavy oncology, gene therapy, or deeply field-led programs that require nurse-led teach-and-train, complex payer-escalation operations, or extensive FRM infrastructure.
• Commercial fit: Pricing is undisclosed; expect RFP-led scope with explicit clarity on which CaryConnect, CaryRx, Clair, and OneDash modules are included.
• Contracting diligence: Confirm BV/PA/copay depth, dedicated vs. shared staffing model, data feeds into manufacturer CRM and analytics environments, and division of labor with partner specialty pharmacies for LDD products.

Differentiators

• CaryRx 50-state digital specialty pharmacy with same-day delivery: Licensed nationwide; same-day delivery in core markets supports DTP launches and acute-onset therapies.
• CaryConnect DTP platform: Branded enrollment, engagement, and fulfillment for manufacturer programs; April 2026 Cipher Pharmaceuticals Natroba (spinosad) launch is a named program signal.
• Clair AI clinical co-pilot: Semantic search across 200M+ clinical studies, 147,000 FDA package inserts, and 2M drug interactions; positions clinical reference and MSL workflow inside the platform.
• OneDash AI care-gap closure for health plans: HEDIS-focused care-gap closure with 73% reported closure rates; differentiator vs. pharma-only hub vendors.
• Measured outcomes: +15% adherence improvement and 73% care-gap closure rates ground the AI claims in operating metrics rather than positioning copy.

RFP Questions

• Which therapy areas have dedicated DTP enrollment and adherence playbooks today?
• What median time-to-therapy, PA turnaround, and first-fill conversion metrics can be reported by brand?
• How are benefit verification, PAP, copay, and adherence data reconciled into manufacturer dashboards through CaryConnect?
• What CaryRx pharmacy licensing, payer contracts, and limited-distribution network access are available for specialty products?
• How does Clair’s clinical-reference output integrate with manufacturer MSL and field-medical workflow?
• What launch-surge staffing, training, and bilingual coverage commitments are available in the first 90 days?

Recent Activity

• 2026-05 - CareTria ownership and CaryConnect / Clair / OnLabel positioning make CaryHealth the CareTria digital pharmacy and DTP access layer rather than a standalone legacy startup.

• 2026-04 - Launched a direct-to-patient program with Cipher Pharmaceuticals for Natroba (spinosad).

• 2025-10 - Launched CaryConnect direct-to-patient platform for manufacturer access programs.

• 2025-08 - Ranked No. 96 on the 2025 Inc. 5000 with 3,752% three-year revenue growth.

• 2025-05 - CEO Areo Nazari named EY Entrepreneur Of The Year 2025 Mid-Atlantic Award finalist.

• 2025-04 - Named #1 Mid-Atlantic fastest-growing private company by Inc.

• 2024-10 - Sponsored the NCQA conference; unveiled OneDash AI-agent enhancements for HEDIS care-gap closure.

• 2024-08 - Launched Clair generative-AI clinical reference tool with semantic search across 200M+ clinical studies and 147,000 FDA package inserts.